Telesis Bio Inc. Quarterly Income Tax Expense (Benefit) in USD from Q2 2020 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Telesis Bio Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2020 to Q3 2024.
- Telesis Bio Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $1K, a 92.9% decline year-over-year.
- Telesis Bio Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $7K, a 74.1% decline year-over-year.
- Telesis Bio Inc. annual Income Tax Expense (Benefit) for 2023 was $24K, unchanged from 2022.
- Telesis Bio Inc. annual Income Tax Expense (Benefit) for 2022 was $24K, a 71.4% increase from 2021.
- Telesis Bio Inc. annual Income Tax Expense (Benefit) for 2021 was $14K, a 180% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)